Our study revealed that 4-carbomethoxyl-10-epigyrosanoldie E suppresses FAK protein expression in oral cancer cells, impacting downstream MAPK proteins and MMPs (Figure 4). This evidence concerns the gene PTK2 and lip and oral cavity carcinoma.